C. Bresson

发表

A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer

Pierre Validire, Yudi Pawitan, Angel Porgador, 2015, Oncotarget.

Precision Medicine Clinical Trials: Successes and Disappointments, Challenges and Opportunities – Lessons Learnt

J. Sicklick, R. Schilsky, W. Symmans, 2018, Predictive Biomarkers in Oncology.

Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies

J. Blay, R. Schilsky, S. Ikeda, 2022, JCO precision oncology.

Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung

J. Blay, R. Schilsky, S. Ikeda, 2022, Therapeutic advances in medical oncology.

Lack of increased urinary calcium-oxalate supersaturation in long-term kidney transplant recipients.

C. Bresson, H. Bittard, M. Henriet, 1997, Kidney international.

No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients.

C. Bresson, J. Regnard, M. Bouhaddi, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Lack of evidence that cyclosporine treatment impairs calcium-phosphorus homeostasis and bone remodeling in normocalcemic long-term renal transplant recipients.

C. Bresson, M. Henriet, G. Dumoulin, 1995, Transplantation.

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

J Jack Lee, Eitan Rubin, Razelle Kurzrock, 2019, Nature Medicine.

Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial.

R. Schilsky, J. Lee, R. Berger, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non‐small cell lung cancer

N. Girard, R. Schilsky, J. Lee, 2022, Cancer medicine.

Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

C. Bresson, B. Hory, C. Pérol, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Survival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates

N. Girard, J. Lee, B. Leyland-Jones, 2019, Annals of Oncology.

Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival

N. Girard, R. Schilsky, R. Berger, 2021, npj Precision Oncology.

A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology

R. Schilsky, E. Felip, M. Ducreux, 2023, Therapeutic advances in medical oncology.

Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumors

R. Schilsky, E. Rubin, C. Bresson, 2024, Therapeutic advances in medical oncology.